Literature DB >> 1655511

GABAergic neurotransmission in the C57BL/10 sps/sps mouse mutant: a model of absence seizures.

J G Ortiz1, A E Negrón, A P Thomas, H Heimer, J A Moreira, M L Cordero, J Aranda, M S Bruno.   

Abstract

The C57BL/10 sps/sps mouse mutant displays generalized absence seizure-like behavior. In these mice, glutamic acid decarboxylase activity is reduced in the cortex and hippocampus. Tritiated flunitrazepam binding (3H-flu) is reduced in these areas, as well as in midbrain, cerebellum, and pons-medulla. Quantitative [3H]-flunitrazepam binding autoradiography confirms these observations. GABA uptake by synaptosomes from sps/sps mice is also reduced in all the areas studied. Potassium-stimulated, Ca(2+)-dependent release of radioactivity from synaptosomes preloaded with [14C]-GABA is reduced in the hippocampus, increased in midbrain and pons-medulla, but remains unaltered in the cortex. These results suggest region-specific alterations in GABAergic neurotransmission that may be responsible for the absence-like seizures in C57BL/10 sps/sps mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655511     DOI: 10.1016/0014-4886(91)90024-7

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

1.  Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release.

Authors:  J G Ortiz; J Nieves-Natal; P Chavez
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  GABA-gated chloride ion influx in brains of tremor rats.

Authors:  K Kishi; M Ito; A Tsuda; H Tsuda; H Shiraishi; H Sejima; C Mori; T Serikawa; J Yamada
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

3.  Altered GABAergic and glutamatergic transmission in audiogenic seizure-susceptible mice.

Authors:  M L Cordero; J G Ortiz; G Santiago; A Negrón; J A Moreira
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.